These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19559011)

  • 1. ATF3 plays a protective role against toxicity by N-terminal fragment of mutant huntingtin in stable PC12 cell line.
    Liang Y; Jiang H; Ratovitski T; Jie C; Nakamura M; Hirschhorn RR; Wang X; Smith WW; Hai T; Poirier MA; Ross CA
    Brain Res; 2009 Aug; 1286():221-9. PubMed ID: 19559011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation.
    Igarashi S; Morita H; Bennett KM; Tanaka Y; Engelender S; Peters MF; Cooper JK; Wood JD; Sawa A; Ross CA
    Neuroreport; 2003 Mar; 14(4):565-8. PubMed ID: 12657886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease.
    Chan EY; Luthi-Carter R; Strand A; Solano SM; Hanson SA; DeJohn MM; Kooperberg C; Chase KO; DiFiglia M; Young AB; Leavitt BR; Cha JH; Aronin N; Hayden MR; Olson JM
    Hum Mol Genet; 2002 Aug; 11(17):1939-51. PubMed ID: 12165556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.
    Jiang H; Poirier MA; Liang Y; Pei Z; Weiskittel CE; Smith WW; DeFranco DB; Ross CA
    Neurobiol Dis; 2006 Sep; 23(3):543-51. PubMed ID: 16766198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
    Wang H; Lim PJ; Karbowski M; Monteiro MJ
    Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
    Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
    Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calmodulin regulates transglutaminase 2 cross-linking of huntingtin.
    Zainelli GM; Ross CA; Troncoso JC; Fitzgerald JK; Muma NA
    J Neurosci; 2004 Feb; 24(8):1954-61. PubMed ID: 14985437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
    Wyttenbach A; Swartz J; Kita H; Thykjaer T; Carmichael J; Bradley J; Brown R; Maxwell M; Schapira A; Orntoft TF; Kato K; Rubinsztein DC
    Hum Mol Genet; 2001 Aug; 10(17):1829-45. PubMed ID: 11532992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dithiol-based compounds maintain expression of antioxidant protein peroxiredoxin 1 that counteracts toxicity of mutant huntingtin.
    Pitts A; Dailey K; Newington JT; Chien A; Arseneault R; Cann T; Thompson LM; Cumming RC
    J Biol Chem; 2012 Jun; 287(27):22717-29. PubMed ID: 22577145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
    Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of N-terminal Huntingtin (Htt552) accumulation by Beclin1.
    Wu JC; Qi L; Wang Y; Kegel KB; Yoder J; Difiglia M; Qin ZH; Lin F
    Acta Pharmacol Sin; 2012 Jun; 33(6):743-51. PubMed ID: 22543707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
    Bates EA; Victor M; Jones AK; Shi Y; Hart AC
    J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3.
    Zainelli GM; Dudek NL; Ross CA; Kim SY; Muma NA
    J Neuropathol Exp Neurol; 2005 Jan; 64(1):58-65. PubMed ID: 15715085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length.
    de Almeida LP; Ross CA; Zala D; Aebischer P; Déglon N
    J Neurosci; 2002 May; 22(9):3473-83. PubMed ID: 11978824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure.
    Poirier MA; Jiang H; Ross CA
    Hum Mol Genet; 2005 Mar; 14(6):765-74. PubMed ID: 15689354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.
    Wellington CL; Ellerby LM; Gutekunst CA; Rogers D; Warby S; Graham RK; Loubser O; van Raamsdonk J; Singaraja R; Yang YZ; Gafni J; Bredesen D; Hersch SM; Leavitt BR; Roy S; Nicholson DW; Hayden MR
    J Neurosci; 2002 Sep; 22(18):7862-72. PubMed ID: 12223539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
    Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
    J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis.
    Miller J; Arrasate M; Shaby BA; Mitra S; Masliah E; Finkbeiner S
    J Neurosci; 2010 Aug; 30(31):10541-50. PubMed ID: 20685997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.
    Boudreau RL; McBride JL; Martins I; Shen S; Xing Y; Carter BJ; Davidson BL
    Mol Ther; 2009 Jun; 17(6):1053-63. PubMed ID: 19240687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.